Chemed (CHE -3%) discloses in a regulatory filing that in July it received an investigative...

Chemed (CHE -3%) discloses in a regulatory filing that in July it received an investigative subpoena from the Florida Attorney General seeking a variety of documents - of which it had previously produced in the course of prior government investigations - regarding billing records and procedures, patient eligibility for hospice care, plus other matters pertaining to its general business operations.

From other sites
Comments (1)
  • Andrew Shapiro
    , contributor
    Comments (2073) | Send Message
    That is not all the incremental regulatory investigative actions that occurred to CHE. Also from the 10-Q


    "In August 2012, the OIG also subpoenaed medical records for 268 patients from three Southern California programs."


    "In September 2012, VITAS received an administrative subpoena from OIG seeking production of medical records for 102 patients in 10 states who received continuous care between 2004 and 2009. "
    2 Nov 2012, 11:50 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs